MYCN and neoplasm: Future research may also evaluate the potency of our B7-H3 CAR-T cells in the tumor microenvironment using immunocompetent mouse tumor models, such as KPC mouse models for pancreatic cancer40 and TH-MYCN transgenic murine model for neuroblastoma41.